These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3378192)

  • 1. Characterization of different cell subpopulations derived from an experimental tumor model.
    Gardner HA; Kellen JA; Wong AH; Szalai JP; Katic M
    Cancer Invest; 1988; 6(2):161-5. PubMed ID: 3378192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen tolerance and steroid receptors in a tumor model.
    Kellen JA; Sutherland DJ
    In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activators as markers of tumor colonization potential.
    Ng R; Kellen JA; Wong AC
    Invasion Metastasis; 1983; 3(4):243-8. PubMed ID: 6689573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human choriogonadotropin-like material correlates with metastatic phenotype of R3230 AC rat adenocarcinoma.
    Acevedo HF; Kellen JA; Wong AC; Gardner HA; Szalai JP
    Cancer Invest; 1987; 5(3):177-85. PubMed ID: 3651864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin resistance and lectin binding in a rat adenocarcinoma.
    Ng R; Kellen JA
    Anticancer Res; 1983; 3(6):421-3. PubMed ID: 6689469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour.
    Williams JC; Gusterson BA; Coombes RC
    Br J Cancer; 1982 Apr; 45(4):588-97. PubMed ID: 7073949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toremifene resistance in a rat mammary tumour model.
    Kellen JA; Georges E; Ling V; Dubsky M
    Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
    van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
    Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamines and hormonal regulation of N-nitrosomethylurea-induced rat mammary tumor growth in vivo.
    Manni A; Wright C; Demers L; Luk G
    Cancer Res; 1986 Oct; 46(10):4938-41. PubMed ID: 3756855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma.
    Buckley ND; Carlsen SA
    Cancer Res; 1988 Mar; 48(6):1451-5. PubMed ID: 3345516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor.
    Geradts J; Richards J; Edery M; Pang K; Larson L; Nandi S
    Cancer Res; 1986 Apr; 46(4 Pt 2):1920-7. PubMed ID: 3004710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estradiol and progesterone receptors in transplantable mouse mammary gland tumors].
    Ivanova Ts; Tsingilev D; Sirakov L
    Eksp Med Morfol; 1982; 21(2):95-9. PubMed ID: 7140628
    [No Abstract]   [Full Text] [Related]  

  • 13. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of fluorescein isothiocyanate conjugated lectins to MXT mouse mammary neoplasm and their relation to steroid receptor status.
    Kiss R; Lenglet G; Danguy A
    Anticancer Res; 1986; 6(2):209-13. PubMed ID: 3085574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Waseda N; Kato Y; Matsushita N; Imura H
    Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of estrogens and anti-estrogens in the rat endometrial adenocarcinoma cell lines RUCA-I and RUCA-II.
    Schütze N; Kraft V; Deerberg F; Winking H; Meitinger D; Ebert K; Knuppen R; Vollmer G
    Int J Cancer; 1992 Dec; 52(6):941-9. PubMed ID: 1459735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats.
    Inoh A; Kamiya K; Fujii Y; Yokoro K
    Jpn J Cancer Res; 1985 Aug; 76(8):699-704. PubMed ID: 3930447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenic properties of clonal cell lines derived from canine mammary carcinomas and sensitivity to tamoxifen and doxorubicin.
    Sartin EA; Barnes S; Toivio-Kinnucan M; Wright JC; Wolfe LG
    Anticancer Res; 1993; 13(1):229-36. PubMed ID: 8476218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma.
    Boccardo F; Cerruti G; De Menech R; Valenti G; Zanardi S
    Oncology; 1987; 44(4):248-52. PubMed ID: 3112670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
    Moreno-Cuevas JE; Sirbasku DA
    In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.